Your browser doesn't support javascript.
loading
Epithelial Ovarian Cancer: A Five Year Review.
Arnaoutoglou, Christos; Dampala, Kalliopi; Anthoulakis, Christos; Papanikolaou, Evangelos G; Tentas, Ioannis; Dragoutsos, Georgios; Machairiotis, Nikolaos; Zarogoulidis, Paul; Ioannidis, Aristeidis; Matthaios, Dimitris; Perdikouri, Eleni I; Giannakidis, Dimitrios; Sardeli, Chrysanthi; Petousis, Stamatios; Oikonomou, Panagoula; Nikolaou, Christina; Charalampidis, Charalampos; Sapalidis, Konstantinos.
Afiliação
  • Arnaoutoglou C; 1st Department of Obstetrics & Gynecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Dampala K; 1st Department of Obstetrics & Gynecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Anthoulakis C; 1st Department of Obstetrics & Gynecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Papanikolaou EG; 3rd Department of Obstetrics & Gynecology, Hippokration Hospital, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Tentas I; Department of Obstetrics & Gynecology, General Hospital of Giannitsa, 581 00 Giannitsa, Greece.
  • Dragoutsos G; Department of Obstetrics and Gynecology, Democritus University of Thrace, 681 00 Alexandroupolis, Greece.
  • Machairiotis N; Fellow in Endometriosis and Minimal Access Surgery, Northwick Park, Central Middlesex and Ealing Hospitals, London North West University Heathcare, NHS Trust, London NW10 7NS, UK.
  • Zarogoulidis P; 3rd University General Hospital, "AHEPA" University Hospital, 546 36 Thessaloniki, Greece.
  • Ioannidis A; Surgery Department, Genesis Private Hospital, 546 26 Thessaloniki, Greece.
  • Matthaios D; Oncology Department, General Hospital of Rhodes, 851 33 Rodos, Greece.
  • Perdikouri EI; Oncology Department, General Hospital of Volos, 382 22 Volos, Greece.
  • Giannakidis D; 1st Department of Surgery, Attica General Hospital "Sismanogleio-Amalia Fleming", 151 26 Athens, Greece.
  • Sardeli C; Department of Pharmacology & Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Petousis S; 2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Oikonomou P; Surgery Department, Democritus University of Thrace, 691 00 Alexandroupolis, Greece.
  • Nikolaou C; Surgery Department, Democritus University of Thrace, 691 00 Alexandroupolis, Greece.
  • Charalampidis C; Pathology Department, University of Cyprus, Nicosia 1678, Cyprus.
  • Sapalidis K; 3rd University General Hospital, "AHEPA" University Hospital, 546 36 Thessaloniki, Greece.
Medicina (Kaunas) ; 59(7)2023 Jun 21.
Article em En | MEDLINE | ID: mdl-37511995
Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article